Sarepta Therapeutics Inc (NASDAQ:SRPT)

30.14
Delayed Data
As of Jul 02
 +0.39 / +1.31%
Today’s Change
11.33
Today|||52-Week Range
33.16
+108.29%
Year-to-Date

Stock Price Forecast

The 13 analysts offering 12-month price forecasts for Sarepta Therapeutics Inc have a median target of 33.00, with a high estimate of 45.00 and a low estimate of 14.00. The median estimate represents a +9.49% increase from the last price of 30.14.

Analyst Recommendations

The current consensus among 15 polled investment analysts is to Buy stock in Sarepta Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$1.19
Sales
$14.7K
Reporting Date
Aug 06

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 20.08%
 
 
 
 
 
 
Growthannually -46.12%
 
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually -99.59%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account